These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38160960)

  • 1. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
    Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
    Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.
    Jaycox JR; Lucas C; Yildirim I; Dai Y; Wang EY; Monteiro V; Lord S; Carlin J; Kita M; Buckner JH; Ma S; Campbell M; Ko A; Omer S; Lucas CL; Speake C; Iwasaki A; Ring AM
    Nat Commun; 2023 Mar; 14(1):1299. PubMed ID: 36894554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
    Karami Fath M; Jahangiri A; Ganji M; Sefid F; Payandeh Z; Hashemi ZS; Pourzardosht N; Hessami A; Mard-Soltani M; Zakeri A; Rahbar MR; Khalili S
    Front Immunol; 2021; 12():705772. PubMed ID: 34447375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
    J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
    Oakes EG; Dillon E; Buhler KA; Guan H; Paudel M; Marks K; Adejoorin I; Yee J; Ellrodt J; Tedeschi S; Sparks J; Case SM; Hsu T; Solomon DH; Jonsson AH; Alexander RV; Rao DA; Choi MY; Costenbader KH
    J Autoimmun; 2024 Sep; 148():103299. PubMed ID: 39096716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion.
    Simon D; Tascilar K; Schmidt K; Manger B; Weckwerth L; Sokolova M; Bucci L; Fagni F; Manger K; Schuch F; Ronneberger M; Hueber A; Steffen U; Mielenz D; Herrmann M; Harrer T; Kleyer A; Krönke G; Schett G
    Arthritis Rheumatol; 2022 Jan; 74(1):33-37. PubMed ID: 34196506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.
    Connolly CM; Teles M; Frey S; Boyarsky BJ; Alejo JL; Werbel WA; Albayda J; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
    Ann Rheum Dis; 2022 Feb; 81(2):291-293. PubMed ID: 34493492
    [No Abstract]   [Full Text] [Related]  

  • 17. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
    Ruggeri RM; Giovanellla L; Campennì A
    J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.